Peter Libby, MD

Peter Libby, MD

Cardiovascular Specialist, Brigham and Women’s Hospital and
Mallinckrodt Professor of Medicine, Harvard Medical School

Peter Libby, M.D., is cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, and holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. His areas of clinical expertise include general and preventive cardiology. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has particular devotion to translate laboratory studies to pilot and then large-scale clinical cardiovascular outcome trials. He instigated and helped to lead the large scale Canakinumab Anti-Inflammatory Thrombosis Outcomes Trial (CANTOS) that provided clinical validation of the role of inflammation in atherosclerosis. 

Dr. Libby’s elected professional memberships include the Association of American Physicians, the American Society for Clinical Investigation, and honorary memberships in the British Atherosclerosis Society, the Japan Circulation Society, and the Japanese College of Cardiology. He also has served in many roles as a volunteer for the American Heart Association. He has received continuous funding from the U.S. National Heart Lung and Blood Institute (NHLBI) for several decades. 

An author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published extensively in top ranked medical journals. He is an editor of Braunwald’s Heart Disease 

Dr. Libby has received numerous awards and recognitions for his research accomplishments, including a number of lifetime achievement awards from various organizations. He has held numerous visiting professorships and delivered more than 150 major named or keynote lectures worldwide. 

Dr. Libby earned his medical degree at the University of California, San Diego, and completed his training in internal medicine and cardiology at the Peter Bent Brigham Hospital (now BWH). He holds honorary doctoratefrom the Université de Lille, France and Université Laval, Québec, Canada, as well as a Doctor Medicinæ Honoris Causa from Johann Wolfgang Goethe University, Frankfurt am Main, Germany.